Back

Extreme HDL-C associated increased mortality is explained by confounding due to progressively increasing alcohol-induced multisystem morbidity

31 August 2026 (12:36 - 12:48)
Organised by: Logo
Congress Presentation Part of: Lipids and myocardial infarction Lipids ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Lipoprotein(a), smoking, and diabetes are additive, but not interactive risk factors for major adverse cardiovascular events after acute coronary syndrome: An analysis of the ODYSSEY OUTCOMES trial
Professor G. Schwartz (Aurora, US)
Abstract Slides
Presentation thumbnail
Sex differences in lipid management among high-risk patients without prior myocardial infarction or stroke: results from the VESALIUS-REAL global study
Associate Professor E. Hagstrom (Uppsala, SE)
Abstract Slides
Presentation thumbnail
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
Doctor F. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
FH genotype stratifies LDL-C–lowering response and improves diagnostic discrimination in severe hypercholesterolemia
Doctor J. Bernhard (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Lipids and myocardial infarction
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 12:36 CET
You may be interested in
thumbnail
Congress Presentation
The change of paradigm: high HDL-c levels could not mean a long lifespan
30 August 2024
thumbnail
Congress Presentation
Alcohol consumption in young men and risk of heart failure and all-cause mortality- a cohort study
27 August 2021
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
4 April 2025
thumbnail
Congress Presentation
Associations of 1- and 3-methylhistidine with long-term risk of acute myocardial infarction and mortality
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources